Last updated: [DATE] · Draft - have this reviewed by a lawyer before publishing
These Terms & Conditions ("Terms") govern your use of the IPOPlus website (the "Site"). By accessing or using the Site, you agree to be bound by these Terms. If you do not agree, please do not use the Site.
IPOPlus is an information platform only. Content on this Site - including IPO details, price bands, grey market premium (GMP) figures, subscription data, and listing performance - is provided for general informational purposes and does not constitute investment advice, a recommendation, or a solicitation to buy or sell any security. IPOPlus is not a SEBI-registered investment adviser, stock broker, or research analyst. Consult a qualified, SEBI-registered investment adviser before making any investment decision.
We source IPO information from public filings, exchange disclosures, and registrar updates, and update it regularly. However, we make no warranty as to the completeness, accuracy, or timeliness of any information on this Site, including GMP figures, which reflect informal and unregulated grey market activity and are not a reliable predictor of listing price or performance. Always verify critical details - price band, dates, allotment status - against the official RHP/DRHP, exchange, or registrar website.
You may use this Site for personal, non-commercial reference. You agree not to scrape, republish, or redistribute substantial portions of the Site's content without prior written permission, and not to use the Site in any way that could damage, disable, or impair it.
This Site links to third-party websites (registrars, exchanges, company websites, DRHP/RHP documents) for your convenience. We do not control and are not responsible for the content, accuracy, or practices of these third-party sites.
To the fullest extent permitted by law, IPOPlus and its operators shall not be liable for any direct, indirect, incidental, or consequential loss or damage arising from your use of, or reliance on, information provided on this Site, including any investment decision made on the basis of GMP figures, subscription data, or any other content.
We may update these Terms from time to time. Continued use of the Site after changes are posted constitutes your acceptance of the revised Terms.
These Terms are governed by the laws of India, and any disputes arising from your use of this Site shall be subject to the exclusive jurisdiction of the courts of [CITY], India.
Questions about these Terms can be sent to [email protected].